Additionally, Sirt2 contributes to cMyc stabilization through deacetylation, and elevated Sirt2/cMyc expression promotes metabolic reprogramming, mitigates oxidative stress, enhances serine biosynthesis, and drives CCA cell proliferation by promoting PDHA1 phosphorylation [59]. Here, MYC is linked to cholangiocarcinoma.